ProMIS Neurosciences Inc ARFXF:OTCQB

RT Quote | Exchange | USD
Last | 04/09/21 EDT
0.176quote price arrow up+0.001 (+0.57%)
Volume
385,350
52 week range
0.04 - 0.23

...

Loading . . .
  • Open0.18
  • Day High0.18
  • Day Low0.1752
  • Prev Close0.175
  • 52 Week High0.23
  • 52 Week High Date06/17/20
  • 52 Week Low0.04
  • 52 Week Low Date12/28/20

Key Stats

  • Market Cap50.79M
  • Shares Out289.73M
  • 10 Day Average Volume782,243.64
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change112.3

KEY STATS

  • Open0.18
  • Day High0.18
  • Day Low0.1752
  • Prev Close0.175
  • 52 Week High0.23
  • 52 Week High Date06/17/20
  • 52 Week Low0.04
  • 52 Week Low Date12/28/20
  • Market Cap50.79M
  • Shares Out289.73M
  • 10 Day Average Volume782,243.64
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change112.3

RATIOS/PROFITABILITY

  • EPS (TTM)-0.02
  • P/E (TTM)-11.32
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From ProMIS Neurosciences Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
ProMIS Neurosciences Inc, formerly Amorfix Life Sciences Ltd, is a Canada-based development-stage biotech company. The Company discovers and develops precision therapeutics with companion diagnostics for early detection and treatment of neurodegenerative diseases, in particular Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). The assays are developed using its technologies, Epitope Protection and AMFIA. It is developing therapies targeting misfolded...
Eugene Williams
Chairman
Elliot Goldstein M.D.
President
Daniel Geffken CPA
Chief Financial Officer
Address
SUITE 200, 1920 YONGE STREET
Toronto, ON
M4S 3E2
Canada